Skip to content

Validation of the 3D-CAM and the UB-CAM in French

Validation of the 3-Minute Diagnostic Interview for CAM-defined Delirium (3D-CAM) and the Ultra-Brief CAM (UB-CAM) in French.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05242887
Acronym
French-UB-CAM
Enrollment
80
Registered
2022-02-16
Start date
2022-03-31
Completion date
2024-03-27
Last updated
2024-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium

Keywords

Delirium, CAM, UB-CAM, 3D-CAM

Brief summary

Delirium is very common in hospitalized older patients and associated with serious clinical bad outcomes (e.g. increased risk of functional decline and death). Despite its high prevalence in the hospital setting, delirium remains underdiagnosed. A better identification would allow an early management and a reduction of its complications. The validation of easy-to-use and quick and formalized tools for the identification of delirium and their implementation in the clinical practice are necessary. Recently, the 3D-CAM (3-minutes Diagnostic interview for Confusion Assessment Method -defined delirium) and the UB-CAM (Ultra-Brief CAM) showed very high sensitivity and specificity (\> 90%), compared to the reference standard (Diagnostic and Statistical Manual of Mental Disorders (DSM criteria)) for the diagnosis of delirium. The investigators aimed to evaluate the sensitivity and specificity of the French versions of the 3D-CAM and the UB-CAM used in delirium screening in older adults hospitalized in geriatric units, compared to reference standard.

Interventions

DIAGNOSTIC_TESTDelirium screening using 3D-CAM and UB-CAM

Patients will be evaluated with 3D-CAM and UB-CAM by a trained examiner (geriatrician, resident or neuropsychologist). On the same day, they will be given a reference diagnosis of delirium based on DSM-V criteria by another trained examiner, blind to the results of the UB-CAM and 3D-CAM.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults hospitalized in acute geriatric units * Aged 65 or older * Patient (or relative) not objecting to participating in the study

Exclusion criteria

\- Legal protection regimes (guardianship, curatorship)

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the performance of a rapid diagnostic tool (UB-CAM) for acute confusional state, translated into FrenchAt inclusionPresence or absence of a confusional state (with UB-CAM and the gold standard: DSM-V criteria)

Secondary

MeasureTime frameDescription
Evaluation of the time taken to use this toolAt inclusionCompletion time (minutes, seconds)
Evaluation of the diagnostic performance of another diagnostic tool (3D-CAM), already translated into FrenchAt inclusionPresence or absence of a confusional state (with 3D-CAM and the gold standard: DSM-V criteria)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026